MNOSX
Price
$34.80
Change
-$0.32 (-0.91%)
Updated
Feb 21 closing price
Net Assets
483.46M
RERBX
Price
$54.18
Change
-$0.50 (-0.91%)
Updated
Feb 21 closing price
Net Assets
131.04B
Ad is loading...

MNOSX vs RERBX

Header iconMNOSX vs RERBX Comparison
Open Charts MNOSX vs RERBXBanner chart's image
Manning & Napier Overseas Series S
Price$34.80
Change-$0.32 (-0.91%)
VolumeN/A
Net Assets483.46M
American Funds Europacific Growth R2
Price$54.18
Change-$0.50 (-0.91%)
VolumeN/A
Net Assets131.04B
MNOSX vs RERBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MNOSX vs. RERBX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNOSX is a Buy and RERBX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 131B vs. MNOSX (483M). RERBX pays higher dividends than MNOSX: RERBX (1.00) vs MNOSX (0.92). MNOSX was incepted earlier than RERBX: MNOSX (6 years) vs RERBX (23 years). MNOSX is a more actively managed with annual turnover of: 49.00 vs. RERBX (34.00). RERBX has a lower initial minimum investment than MNOSX: RERBX (250) vs MNOSX (2000). MNOSX annual gain was more profitable for investors over the last year : 11.62 vs. RERBX (0.62). MNOSX return over 5 years is better than : 41.01 vs. RERBX (4.32).
MNOSXRERBXMNOSX / RERBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years23 years-
Gain YTD8.1756.549125%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets483M131B0%
Annual Yield % from dividends0.921.0092%
Returns for 1 year11.620.621,880%
Returns for 3 years8.86-0.32-2,802%
Returns for 5 years41.014.32949%
Returns for 10 yearsN/A15.57-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KFS7.66-0.01
-0.13%
Kingsway Financial Services
ENLV1.00-0.02
-1.81%
Enlivex Therapeutics Ltd
PGRE4.52-0.10
-2.16%
Paramount Group
PTC161.65-4.11
-2.48%
PTC
RNA31.12-1.41
-4.33%
Avidity Biosciences